BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38609388)

  • 1. Endothelial DR6 in blood-brain barrier malfunction in Alzheimer's disease.
    Huang X; Qi J; Su Y; Zhou Y; Wang Q; Huang T; Xue D; Zeng Y; Verkhratsky A; Zhou B; Chen H; Yi C
    Cell Death Dis; 2024 Apr; 15(4):258. PubMed ID: 38609388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of Wnt/β-catenin pathway mitigates blood-brain barrier dysfunction in Alzheimer's disease.
    Wang Q; Huang X; Su Y; Yin G; Wang S; Yu B; Li H; Qi J; Chen H; Zeng W; Zhang K; Verkhratsky A; Niu J; Yi C
    Brain; 2022 Dec; 145(12):4474-4488. PubMed ID: 35788280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNF-α and IL-1β Modulate Blood-Brain Barrier Permeability and Decrease Amyloid-β Peptide Efflux in a Human Blood-Brain Barrier Model.
    Versele R; Sevin E; Gosselet F; Fenart L; Candela P
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dickkopf-related protein-1 inhibition attenuates amyloid-beta pathology associated to Alzheimer's disease.
    Menet R; Bourassa P; Calon F; ElAli A
    Neurochem Int; 2020 Dec; 141():104881. PubMed ID: 33068684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysfunction of the blood-brain barrier in Alzheimer's disease: Evidence from human studies.
    Kurz C; Walker L; Rauchmann BS; Perneczky R
    Neuropathol Appl Neurobiol; 2022 Apr; 48(3):e12782. PubMed ID: 34823269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A death receptor 6-amyloid precursor protein pathway regulates synapse density in the mature CNS but does not contribute to Alzheimer's disease-related pathophysiology in murine models.
    Kallop DY; Meilandt WJ; Gogineni A; Easley-Neal C; Wu T; Jubb AM; Yaylaoglu M; Shamloo M; Tessier-Lavigne M; Scearce-Levie K; Weimer RM
    J Neurosci; 2014 May; 34(19):6425-37. PubMed ID: 24806669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astaxanthin exerts protective effects similar to bexarotene in Alzheimer's disease by modulating amyloid-beta and cholesterol homeostasis in blood-brain barrier endothelial cells.
    Fanaee-Danesh E; Gali CC; Tadic J; Zandl-Lang M; Carmen Kober A; Agujetas VR; de Dios C; Tam-Amersdorfer C; Stracke A; Albrecher NM; Manavalan APC; Reiter M; Sun Y; Colell A; Madeo F; Malle E; Panzenboeck U
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2224-2245. PubMed ID: 31055081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood-brain barrier dysfunction underlying Alzheimer's disease is induced by an SSAO/VAP-1-dependent cerebrovascular activation with enhanced Aβ deposition.
    Solé M; Esteban-Lopez M; Taltavull B; Fábregas C; Fadó R; Casals N; Rodríguez-Álvarez J; Miñano-Molina AJ; Unzeta M
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2189-2202. PubMed ID: 31047972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid-Beta Peptides 40 and 42 Employ Distinct Molecular Pathways for Cell Entry and Intracellular Transit at the Blood-Brain Barrier Endothelium.
    Wang Z; Sharda N; Omtri RS; Li L; Kandimalla KK
    Mol Pharmacol; 2023 Nov; 104(5):203-213. PubMed ID: 37541759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Type I interferon signaling and brain endothelial barrier dysfunction in an experimental model of Alzheimer's disease.
    Jana A; Wang X; Leasure JW; Magana L; Wang L; Kim YM; Dodiya H; Toth PT; Sisodia SS; Rehman J
    Sci Rep; 2022 Oct; 12(1):16488. PubMed ID: 36182964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Death receptors DR6 and TROY regulate brain vascular development.
    Tam SJ; Richmond DL; Kaminker JS; Modrusan Z; Martin-McNulty B; Cao TC; Weimer RM; Carano RA; van Bruggen N; Watts RJ
    Dev Cell; 2012 Feb; 22(2):403-17. PubMed ID: 22340501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sialic acid (SA)-modified selenium nanoparticles coated with a high blood-brain barrier permeability peptide-B6 peptide for potential use in Alzheimer's disease.
    Yin T; Yang L; Liu Y; Zhou X; Sun J; Liu J
    Acta Biomater; 2015 Oct; 25():172-83. PubMed ID: 26143603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid-beta impairs insulin signaling by accelerating autophagy-lysosomal degradation of LRP-1 and IR-β in blood-brain barrier endothelial cells in vitro and in 3XTg-AD mice.
    Gali CC; Fanaee-Danesh E; Zandl-Lang M; Albrecher NM; Tam-Amersdorfer C; Stracke A; Sachdev V; Reichmann F; Sun Y; Avdili A; Reiter M; Kratky D; Holzer P; Lass A; Kandimalla KK; Panzenboeck U
    Mol Cell Neurosci; 2019 Sep; 99():103390. PubMed ID: 31276749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer's disease.
    Festoff BW; Sajja RK; van Dreden P; Cucullo L
    J Neuroinflammation; 2016 Aug; 13(1):194. PubMed ID: 27553758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta amyloid-induced upregulation of death receptor 6 accelerates the toxic effect of N-terminal fragment of amyloid precursor protein.
    Xu Y; Wang D; Luo Y; Li W; Shan Y; Tan X; Zhu C
    Neurobiol Aging; 2015 Jan; 36(1):157-68. PubMed ID: 25150572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
    Shackleton B; Crawford F; Bachmeier C
    Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).
    Do TM; Dodacki A; Alata W; Calon F; Nicolic S; Scherrmann JM; Farinotti R; Bourasset F
    J Alzheimers Dis; 2016; 49(2):287-300. PubMed ID: 26484906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-malaria drug artesunate prevents development of amyloid-β pathology in mice by upregulating PICALM at the blood-brain barrier.
    Kisler K; Sagare AP; Lazic D; Bazzi S; Lawson E; Hsu CJ; Wang Y; Ramanathan A; Nelson AR; Zhao Z; Zlokovic BV
    Mol Neurodegener; 2023 Jan; 18(1):7. PubMed ID: 36707892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysfunctional Wnt/β-catenin signaling contributes to blood-brain barrier breakdown in Alzheimer's disease.
    Liu L; Wan W; Xia S; Kalionis B; Li Y
    Neurochem Int; 2014 Sep; 75():19-25. PubMed ID: 24859746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Blood-Brain Barrier in Alzheimer's Disease.
    Cai Z; Qiao PF; Wan CQ; Cai M; Zhou NK; Li Q
    J Alzheimers Dis; 2018; 63(4):1223-1234. PubMed ID: 29782323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.